Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo(®) 200) in the treatment of Parkinson’s disease: a case series

Levodopa continues to be the most efficacious and widely used treatment for Parkinson’s disease. Levodopa dosing is understood to be critical for the optimal control of symptoms, and increasing the levodopa dose is a common method to treat advancing disease. Escalating levodopa dosages coupled with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethi, Kapil D, Hauser, Robert A, Isaacson, Stuart H, McClain, Terry
Formato: Texto
Lenguaje:English
Publicado: Cases Network Ltd 2009
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740140/
https://www.ncbi.nlm.nih.gov/pubmed/19829918
http://dx.doi.org/10.4076/1757-1626-2-7134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740140/
https://www.ncbi.nlm.nih.gov/pubmed/19829918
http://dx.doi.org/10.4076/1757-1626-2-7134

Ejemplares similares